期刊文献+

原发性子宫颈透明细胞腺癌32例临床病理分析

Primary clear cell adenocarcinoma of the uterine cervix:a clinicopathological analysis of 32 patients
原文传递
导出
摘要 目的探讨原发性子宫颈透明细胞腺癌(PCCAC)的临床病理特征及预后。方法收集2013年1月至2023年1月山东大学齐鲁医院收治的PCCAC患者32例,分析其临床病理特点,通过log-rank检验探索患者生存的相关影响因素。结果32例患者中位年龄48岁,均接受子宫切除术+盆腔淋巴结切除术,其中5例保留单侧/双侧卵巢。中位随访时间45个月(1~116个月),1例失访,3例因疾病复发转移引起多器官功能衰竭死亡,1例术后复发经综合治疗预后良好,其余患者随访过程中未见复发和转移。log-rank检验提示,年龄>50岁、已绝经、内生型/颈管型以及宫体受累与较差的预后相关(P<0.05)。结论年龄>50岁、已绝经、内生型/颈管型以及宫体受累可能是影响PCCAC患者生存的预后因素,保留卵巢与否似并不影响患者预后。 Objective To investigate the clinical and pathological features and prognosis of primary clear cell adenocarcinoma of the uterine cervix(PCCAC).Methods Thirty-two patients diagnosed with PCCAC and treated at Qilu Hospital of Shandong University from January 2013 to January 2023 were collected,their clinical and pathological characteristics were analyzed,and the Log-rank test was performed to explore factors associated with patient survival.Results The median age of the thirty-two patients was 48 years.All patients underwent hysterectomy and pelvic lymphadenectomy,and the unilateral or bilateral ovaries were preserved in 5 cases.The median follow-up was 45 months(ranging,1-116 months),1 case was lost to followup,3 patients died of multiple organ dysfunction syndrome due to recurrence and metastasis,and 1 patient recurred but the prognosis was good after comprehensive treatment;no recurrence or metastasis was found in the follow-up of the remaining patients.Log-rank test showed that age>50 years,menopause,endogenous or cervical canal type and corpus uteri invasion were associated with worse prognosis(P<0.05).Conclusion Age>50 years,menopause,endogenous or cervical canal type and corpus uteri invasion may be prognostic factors for survival of PCCAC patients.Ovarian preservation does not seem to affect the prognosis of patients.
作者 倪新雨 屈庆喜 张师前 NI Xin-yu;QU Qing-xi;ZHANG Shi-qian(Department of Obstetrics and Gynecology,Qilu Hospital of Shandong University,Jinan 250000,China)
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2024年第3期344-348,共5页 Chinese Journal of Practical Gynecology and Obstetrics
基金 山东省医学会临床科研资金(YXH2022ZX145)。
关键词 子宫颈透明细胞腺癌 预后 卵巢转移 保留卵巢 clear cell adenocarcinoma of the uterine cervix prognosis ovarian metastasis ovarian-preserving
  • 相关文献

参考文献4

二级参考文献30

  • 1周艳,张春菊,吴爱华.绝经后妇女宫颈癌临床分析[J].泰山医学院学报,2008,29(4):270-271. 被引量:2
  • 2倪型灏,冯文华,张谷,李筠,张平.13例宫颈透明细胞腺癌临床病理及免疫组化分析[J].临床与实验病理学杂志,1995,11(3):189-191. 被引量:5
  • 3妇产科诊断病理学[M].回允中译.北京:北京大学医学出版社,2007:291-297.
  • 4Kaminski PF, Maier RC. Clear cell adenomcarcinoma of the cervix unrelated to diethylstilbestrol exposure [ J ]. Obstet Gynecol, 1983, 62(6) : 720-727.
  • 5Hanselaar A, Loosbroek MV, Schuurbiers O, et al. Clear cell adenocarcinoma of ervix and vagina. An update of the Central Netherlands Registry showing twin age incidence peaks [ J ]. Cancer,1997, 79 ( 11 ) :2229-2236.
  • 6Thomas MB, Wright JD, Leiser AL, et al. Clear cell carcinoma of the cervix :a multi-institutional review in the post-DES era [ J ]. Gynecol Oncol, 2008,109 ( 3 ) : 335-339.
  • 7Melnick S, Cole P, Anderson D, et al. Rates and risks of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix: an update[J]. N Engl J Med,1987 ,316 :514-516.
  • 8Reich O, Tamussino K, Lahousen M, et al. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stageIB-IIB disease in women not exposed in utero to diethylstilbestrol[ J]. Gynecol Oncol,2000,76:331-335.
  • 9Boyd J, Takahashi H, Waggoner SE, et al. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethyl stilbestrol exposure in utero[J]. Cancer, 1996,77: 507-513.
  • 10Pirog EC, Kleter B, Semra O, et al. Prevalence of human papillomavirus DNA indifferent histological subtypes of cervical adenocarcinoma[ J ]. Am J Pathol,2000,157 : 1055-1062.

共引文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部